<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN"><html lang="en">	<head>		<meta http-equiv="Content-Type" content="text/html; charset=utf-8">		<meta name="viewport" content="width=device-width, initial-scale=1">		<title></title>		<link rel="stylesheet" href="css/ka.css" type="text/css">		<link rel="stylesheet" href="css/animate.css" type="text/css">		<script type="text/javascript" src="js/base.js"></script>		<script type="text/javascript" src="js/Common.js"></script>		<style type="text/css">.charttabwrap { visibility: hidden; }		</style>		<script type="text/javascript" charset="utf-8">				var ANIMATION = [				custom('.charttabwrap','visibility: visible;'),'q'			];		</script>	</head>	<body class="slide-27">		<div id="main">			<div id="content">				<div class="whiteoverlay"></div>				<div id="logo">					<img src="images/blkAbbott_logo.png" width="154" height="52" alt="Abbott">				</div>				<h1>					Resistance findings<sup>2</sup>				</h1>				<div class="charttabwrap">					<div id="chartwrap">						<div id="leftchart" class="frame-1" onclick="makecall('PopupMessageHTML',Array('ka-27-chart-01','Resistance Chart 1','450','330','0','0','830','470'));"></div>						<div id="leftchart-2" class="frame-2">							<div style="height: 387px; width: 548px; display: block; cursor: pointer;" ontouchend="makecall('PopupMessageHTML',Array('ka-27-chart-02','Resistance Chart 2','450','360','0','0','830','575'));"></div>						</div>						<div class="switch_tabwrap">							<div class="tab dot active" ontouchend="animateTo(0);">								<a href="#">SWITCHMRK 1</a>							</div>							<div class="tab dot" ontouchend="animateTo(0);">								<a href="#">SWITCHMRK 2</a>							</div>						</div>					</div>					<div class="smallcap frame-1">						<div class="left">							<div>								<span class="symbol">*</span> Data derived by population sequencing. All amino acid changes from baseline observed in any of multiple independent PCR reactions are listed without regard to linkage.<br>							</div>							<div>								<span class="symbol">†</span> Phenotypic analysis of the viruses with mutations showed decreased susceptibility to the study drug.<br>							</div>						</div>						<div class="right">							<span class="symbol">‡</span> RTI mutations do not necessarily reflect &nbsp;&nbsp;&nbsp;concurrent OBT arms.<br>							<span class="symbol">§</span> InSTI=Integrase strand transfer inhibitor mutations.						</div>					</div>					<div class="smallcap frame-2">						<div class="left">							<div>								<span class="symbol">*</span> Data derived by population sequencing. All amino acid changes from baseline observed in any of multiple independent PCR reactions are listed without regard to linkage.<br>							</div>						</div>						<div class="right" style="">							<div>								<span class="symbol">†</span> Phenotypic analysis of the viruses with mutations showed decreased susceptibility to the study drug.<br>							</div>							<div>								<span class="symbol">‡</span> RTI mutations do not necessarily reflect concurrent OBT arms.							</div>							<div>								<span class="symbol">§</span> InSTI=Integrase strand transfer inhibitor mutations.							</div>							<div>								<span class="symbol">||</span> The importance of the Y143Y/S mutation is currently unknown.							</div>						</div>					</div>				</div>				<div id="rightcol">					<div class="blk_bullet">						14/16 patients with confirmed virologic failure and vRNA &gt;400 copies/mL underwent genotypic resistance testing.					</div>					<div class="blk_bullet">						8/11 assessable patients who rebounded on raltegravir-based therapy showed raltegravir resistance.					</div>					<div class="hyphenbullet">						5 of these 8 patients showed resistance mutations in the reverse transcriptase gene.					</div>					<div class="blk_bullet">						1 of the 3 assessable patients who rebounded on KALETRA-based therapy showed PI and reverse transcription mutations.					</div>					<h2>						KALETRA resistance considerations					</h2>					<div class="blk_bullet">						<strong>Because the potential for HIV cross-resistance among protease inhibitors has not been fully explored in KALETRA-treated patients, it is unknown what effect therapy with KALETRA will have on the activity of subsequently administered PIs.</strong>					</div>					<div class="blk_bullet">						<strong>Resistance to KALETRA has emerged in patients treated with other PIs prior to KALETRA therapy.</strong>					</div>				</div>				<div class="btns">					<div class="studybtn">						<a href="#"><img src="images/Button-StudyDesignA.png" width="132" height="42" alt="Study Design" onclick="makecall('PopupMessageHTMLWithTopnav',Array('ka-19-popup-01','&lt;DIV align=\'left\'&gt;&lt;font color=\'white\' face=\'Helvetica\'&gt;&lt;p &gt;&lt;strong&gt;}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}Study Design&lt;/strong&gt;&lt;/p&gt;&lt;/font&gt;&lt;/DIV&gt;','780','670','10','0','575','460'));"></a>					</div>					<div class="baselinebtn">						<a href="#"><img src="images/Button-Baseline_A.png" width="132" height="42" alt="Baseline Values" onclick="makecall('PopupMessageHTMLWithTopnav',Array('ka-19-popup-02','&lt;DIV align=\'left\'&gt;&lt;font color=\'white\' face=\'Helvetica\'&gt;&lt;p &gt;&lt;strong&gt;}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}Baseline Values&lt;/strong&gt;&lt;/p&gt;&lt;/font&gt;&lt;/DIV&gt;','920','670','10','0','580','350'));"></a>					</div>				</div>				<div id="footer">					<p>						Please click buttons above for indication<br>						and Important Safety Information about KALETRA.					</p>				</div>			</div>		</div>	</body></html>